본문 바로가기
주메뉴 바로가기
HLBELL
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
Sitemap
Contact
ENG
KOR
ENG
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
SITEMAP
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
PR
Biotech Company Specialized in Regenerative Medicine
News
Notice
News
News
[HLB 동탄연구소]②한용해 CTO “‘포스트 리보세라닙’ 씨앗, R&D 집단지성의 힘”
Date 2025.06.19
Hit 3974
기사원문 : https://
www.press9.kr/news/articleView.html?idxno=64485
PREV
HLB셀, 의료기기 K-GMP 인증 획득…지혈제 '블리픽스' 상업화 가속
NEXT
[HLB 동탄연구소]①그룹 R&D 심장 최초 공개, ‘바이오 집현전’ 방문기
LIST